Antimicrobial Deck 3 Flashcards

1
Q

Gram + Cocci

A

SSE

staph, strep, enterococcus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gram - Cocci

A

H.Flu
Neisseria
Moxaxella

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Gram - Bacilli

A

EKP
ESP

Escherichia coli
Klebsiella pnemonaie, Klebsiella oxytoca
Proteus mirabilis

Enterobacter sp.
Serratia marcescens
Providencia stuartii
Salmonella enteritis
Shigella sp.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Psudomonas

A

Psudomonas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anaerobes

A

Bacteroides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mycoplasms

A

– Mycoplasma: CAP
– Ureaplasma: GU

community acquired pneumona

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Chlamydia

A

– GU
– Respiratory
– Eye

dies when outside of the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ricketssias

A

• Ricketssias
– Ricketssia: Rocky Mountain Spotted fever
– Ehrlichia: tick‐borne

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

• Acid‐fast

A

– Mycobacterium tuberculosis

– Nocardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

• Fungal‐like

A

– Actinomyces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Spirochetes

A
Borrelia burgdorferie (Lyme Disease)
Treponema P llid a um (S hili ) (Syphilis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

• Borrelia burgdorferie (Lyme Disease) treatment

A

– Doxycycline, Amoxicillin

– Cephalosporin 3rd/4th Gen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treponema P llid a um (S hili ) (Syphilis) treatment

A

– Pen G 2.4 million units
– PCN Allergy: Doxy/Tetracycline
– Azithromycin but multiple resistant strains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Gram Positive

A

thick peptidoglycan layer in the cell - purple

thicker cell wall
no porin channels
simpler organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gram negative

A

does not have a peptidoglycan layer - pink

thinner cell wall
lipopoysaccharide outer membrane
porin channels
more complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Staph clinical associations

A

skin, soft tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Strep clincial associations

A

respiratory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

enterococcus clinical manifications

A

GI/GU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

H.Flu Clinical Associations

A

AOM, sinusitis, bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Neisseria clinical associations

A

Meningitis

GU

21
Q

Morxella clinical associations

A

AOM, sinusitis, bronchitis

22
Q

EKP clinical associations

A

Infection: UTI, GI

23
Q

ESP clinical associations

24
Q

Salmonella, shigella clinical associations

25
Pseudomonas clinical associations
pneumonia, various
26
Bacteroides clinical associations
GI, Aspiration pneumonia
27
Goal of Using the Simplified Pathogen | List
Match the drug to the bug • Identify the most likely pathogen • Describe the spectrum of activity of an antibiotic (or antibiotic class) • Develop a simplified “drugs of choice” list
28
• Gram + activity
Staph, Strep
29
• Some Gr‐ activity
EKP(E. coli, Klebsiella, Proteus)
30
• Good Gr – activity
ESP (Enterobacter Enterobacter, Serratia Serratia, Providencia Providencia) • +/‐ pseudomonas
31
Anaerobic activity
Bacteroides
32
Factors to Consider When Prescribing | Antimicrobials
* Site of Infection * Pathogen * Extent of Infection * Purpose * Host
33
Host Criteria
``` – Immune status – Comorbidities – Age – Genetic Factors – Allergies – Pregnancy and Lactation ```
34
Systematic Approach for Selecting | Antimicrobial Agents
Confirm the presence of infection Identification of the likely pathogen Selection of presumptive therapy Monitor therapeutic response
35
Broad Spectrum
• Broad activity against Gram + and Gram – Organisms
36
Examples of broad
``` • Tetracyclines, phenicols, fluoroquinolones, “third‐generation” and “fourth‐ generation” cephalosporins ```
37
Narrow Spectrum
• Limited activity and are primarily only useful against particular species of microorganisms
38
Narrow Glycopeptides PCNs are mainly affective
against Gram+ bacteria
39
Narrow polymixins are usually only effective against
Gram‐ bacteria
40
Narrow aminoglycosides and sulfonamides are mainly effective against
aerobic organisms
41
Narrow nitroimidazoles are generally only effective
for anaerobes
42
``` Penicillin Ampicillin Amoxicillin Penicillin G Treats ```
Gram + (SSE) Strep, Staph, Enterococcus Skin, soft tissue, respiratory
43
Penicillin Extended Spectrum Treats
Less Gr+, more Gr‐ (EKP, ESP) E‐coli, Shigella, Salmonella, Proteus β lactamase Gr + GU G Skin/soft tissue, resp y iratory
44
Tetracyclines Doxycycline Minocycline Treats
``` Gr – Atypicals, MRSA chlamydiae, mycoplasmas, and rickettsiae, and protozoan parasites Propionibacterium acnes Gr+ Strep pneumonaie Skin GU/GI Respiratory Sulfonamide TMP‐SMX Gr‐ E coli, Proteus, Klebsiel ```
45
Cephalosporins 1st Generation cephadroxil Cephalexin Treats
Gram + Staph, Strep, Enterococcus (SSE) Resp, skin/soft tissue
46
``` Cephalosporins 2nd Generation cefprozil cefaclor cefuroxime ``` Treats
Gr+, weak Gr‐ Staph, Strep, Enterococcus (SSE) Resp
47
``` 3rd Generation cefotaxime cefpodoxime cefdinir ceftazidime ceftriazone ``` Treats
``` Weak Gr+, Gr‐ β lactamase H‐Flu, E‐coli, Klebsiella, Proteus (EKP) ESP ``` Resp, GU, GI
48
4th Generation Cefepime Treats
β lactamase Enhanced Gr‐, polymicrobial infections (ESP, EKP, SSE) Resp, GI, GU
49
5th Generation Ceftaroline Treats
Gr+, Gr‐ MRSA , DRSP GI, GU, Skin, Resp